MedPath

M-254

Generic Name
M-254

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: FP
Drug: Placebo
First Posted Date
2007-08-17
Last Posted Date
2016-12-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
23
Registration Number
NCT00517634
Locations
🇬🇧

GSK Investigational Site, Manchester, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath